CLINICAL_TRIALS trial_result · 2024-04-24

Clinical Trial Update: Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE) [Phase 2]

Phase 2 trial update for HOPE-OLE evaluating cardiomyopathy progression in Duchenne Muscular Dystrophy; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Capricor Inc. | Conditions: Duchenne Muscular Dystrophy | Phase 2 | Status: COMPLETED | Results posted: 2024-04-24